Literature DB >> 788955

Difficulties and pitfalls in the interpretation of screening tests for the detection of inborn errors of metabolism.

A Hill, R Casey, W A Zaleski.   

Abstract

A review of factors which may be responsible for false positive and false negative results in a screening program for the detection of inborn errors of metabolism is presented. Administration of medication, dietary therapy, chemical treatment of specimens, delay in analysis, hypersensitivity of procedures utilized, interfering metabolites and inadequate metabolic development or enzymatic maturation in the patient may all produce results resembling an actual inborn error of metabolism. Inadequate nutritional intake prior to procurement of specimen and loss of material during analytical procedures may produce false negative results. As well, certain less severe variants of inborn errors may present in an unusual manner or may only present during periods of stress to the patient. These factors are discussed in relation to the performance of a metabolic screening program. It is suggested that these progrms should be performed by specialized, central laboratories experienced in the complexities of detection of inborn errors of metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 788955     DOI: 10.1016/0009-8981(76)90032-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Biochemical screening in mental retardation.

Authors:  B S Rao; N Jayasimha; M N Subhash
Journal:  Indian J Pediatr       Date:  1981 Mar-Apr       Impact factor: 1.967

2.  Biochemical screening and mental retardation.

Authors:  B S Sridhara Rama Rao; N Jayasimha; M N Subhash
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

3.  Biochemical and clinical studies of a new case of alpha-aminoadipic aciduria.

Authors:  R E Casey; W A Zaleski; M Philp; I S Mendelson; S L MacKenzie
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

4.  Ascorbic acid: an unstable ninhydrin-positive urinary constituent running with valine in a commonly used screening system.

Authors:  R J Pollitt; B Sandhu
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

Review 5.  The Progress and Future of US Newborn Screening.

Authors:  Michael S Watson; Michele A Lloyd-Puryear; R Rodney Howell
Journal:  Int J Neonatal Screen       Date:  2022-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.